MedPath

Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency

Completed
Conditions
Aromatic L-amino Acid Decarboxylase Deficiency
Registration Number
NCT02399761
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency.

Detailed Description

Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency. The routine newborn screening dried blood spots sample will be used to test if 3-O-methyldopa (3-OMD) concentration elevates. If positive of screening test, further confirmation tests including physical examination and for mutation. Genetic counseling and treatment option will be provided, too.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
154795
Inclusion Criteria
  • Babies born in Taiwan receive regular new born screening suggested by Ministry of Heath and Welfare.
  • Parents or Legal Guardian sign in the informed consent form.
Exclusion Criteria
  • Parents or Legal Guardian do not agree to sign in the informed consent form.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of newborns with AADC deficiency3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

National Taiwan University Hospital
🇨🇳Taipei, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.